An email obtained by The Associated Press states that FDA leadership are “allowing review staff and supervisors to resume telework” at least two days a week.

THURSDAY, April 10, 2025 (HealthDay News) -- Weeks after ordering staff back to the office, the U.S. Food and Drug ...